Arizona sues drugmakers Dec 8, 2005
William HermannThe Arizona RepublicDec. State Attorney General Terry Goddard filed a suit Wednesday against 42 drug companies he claims have cheated Arizona consumers and Medicare out of tens of millions of dollars through inflated drug prices. (AZCentral -- News)
42 drug companies sued Dec 8, 2005
Dec. 7, 2005 07:30 PM. Here is a list of the companies sued by Attorney General Terry Goddard. (AZCentral -- News)
Business news in brief Nov 30, 2005
Sicor Inc., Irvine, Calif. is the Teva subsidiary that develops and sells generic injectable medicines. (Philly.com -- Business)
Teva Pharmaceutical says profit, revenue up Nov 12, 2005
Seligman of S in a note yesterday that he was encouraged by Teva's expanding product pipeline, and "revenue synergies" from buying Sicor Inc. in 2004. He sees as other positives for Teva the Medicare drug benefit, pending expiration of more big drug patents, and the purchase of Ivax. (Philly.com -- Health)
PDI, Inc. Appoints Jack E. Stover to the Board of Directors Aug 10, 2005
To track stocks Register. SADDLE RIVER, N.J., Aug. 9 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: - ) a diversified sales and marketing services provider to the biopharmaceutical and medical devices and diagnostics industries, is pleased to announce that Jack E. Stover has been appointed to its Board of Directors and will serve on its Audit Committee. (Yahoo Finance -- Business Services)
Regional firm Teva will buy rival Ivax Jul 28, 2005
In January 2004, it bought Sicor Inc., of Irvine, Calif. for $3. (Philly.com -- Health)
Teva bids big to stay king of generics Jul 26, 2005
1 billion acquisition of Sicor Inc. in January 2004, according to Bloomberg data. Teva is Israel's largest company by market value at $19. (Newsday -- Business)
Astellas And King File Lawsuit Against Adenoscan(R) Generic for Patent Infringement in The USA May 27, 2005
May 27 /PRNewswire-FirstCall/ -- King Pharmaceuticals Research and Development, Inc. ("King") along with Astellas US LLC and Astellas Pharma US, Inc. ("Astellas") announced today that they have filed a patent infringement lawsuit in the United States against Sicor Inc., Sicor Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. (collectively, "Sicor") regarding submission of an abbreviated new drug application ("ANDA") for a generic version of... (PR Newswire)
Astellas and Item File Lawsuit Against Adenoscan(R) Generic For Patent Infringement in the USA May 27, 2005
May 27 /PRNewswire/ -- Astellas US LLC and Astellas Pharma US, Inc. ("Astellas") along with ITEM Development AB ("Item") announced today that they have filed a patent infringement lawsuit in the United States against Sicor Inc., Sicor Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries, Ltd. (collectively, "Sicor") regarding submission of an abbreviated new drug application ("ANDA") for a generic version of Adenoscan(R) (adenosine injection), a pharmacologic... (PR Newswire)
Teva to Report First Quarter 2005 Financial Results on May 3, 2005 Apr 22, 2005
Important factors that could cause or contribute to such differences include Teva's ability to successfully develop and commercialize additional pharmaceutical products, the introduction of competitive generic products, the impact of competition from brand-name companies that sell or license their own generic products (so called "authorized generics") or successfully extend the exclusivity period of their branded products, the effects of competition on Copaxone sales, Teva's ability to rapidly... (Yahoo Finance -- Biotechnology & Drugs)
